CTOR NASDAQ
Citius Oncology, Inc.
1W: -9.5%
1M: +22.2%
3M: +34.0%
YTD: -12.0%
1Y: -51.8%
$0.95
-0.03 (-3.06%)
Weekly Expected Move ±13.4%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$7M
Revenue
+0.0% YoY
$-46M
Net Income
-73.3% YoY
$-20M
Free Cash Flow
-439.1% YoY
-48.1%
Gross Margin
-583.5%
Op. Margin
-597.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-126.6%
ROA-45.2%
ROIC-109.8%
Valuation
P/E-2.0
P/B2.5
EV/EBITDA-1.5
Leverage
Debt/Equity0.25
Current Ratio0.73
Interest Cov.-83.0x
Quality Scores
Piotroski F3/9
Altman Z-2.17
Beneish M0.00